Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · International Stock · T. Rowe Price

T. Rowe Price Overseas Stock Fund T. Rowe Price Overseas Stock Fund (TROSX)

Ticker TROSX · Since 2006-12-29 · · Holdings as of Jul 31, 2026

Expense ratio
0.78%$78/yr per $10k
5-yr return
+4.4%annualized
1-yr return
+2.9%as of Dec 2024
Net assets
$24.8Ball share classes
Holdings
142

Bottom line

Is TROSX a good fund? The bottom line

TROSX is a share class of T. Rowe Price Overseas Stock Fund, a managed international stock mutual fund from T. Rowe Price.

Its expense ratio is 0.78% — about $78 a year on every $10,000 invested, cheaper than 65% of international stock funds we track.

It returned +2.9% over one year, +4.4% a year over five years, +5.1% a year over ten (as of Dec 31, 2024, per its prospectus).

With $24.8 billion in net assets and 142 holdings, its largest position is Asml Holding Nv (3.1%) and the top 10 make up 18.9% of the portfolio.

What stands out

  • Large and established ($24.8 billion)

Updated Nov 19, 2026

What TROSX invests in

The fund seeks long-term growth of capital through investments in the common stocks of non-U.S. companies.

The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in non-U.S. stocks. The fund relies on MSCI Inc., a third-party provider of benchmark indexes and data services, or another unaffiliated data provider to determine the country assigned to a security. Any derivatives that provide exposure to the investment focus suggested by the funds name, or to one or more market risk factors associated with the investment focus suggested by the funds name, are counted (as applicable) toward compliance with the funds 80% investment policy. The fund expects to invest significantly outside the U.S. and to diversify broadly among developed markets and, to a lesser extent, emerging market countries throughout the world. In addition, the fund typically invests at least 65% of its net assets in stocks of large-cap companies. The fund takes a core approach…

From the fund's prospectus (filed Dec 22, 2025).

TROSX performance

Fund calendar-year total returns, 2015–2024 2015: −2.6%; 2016: +2.9%; 2017: +27.0%; 2018: −15.0%; 2019: +22.9%; 2020: +9.2%; 2021: +12.2%; 2022: −15.4%; 2023: +16.3%; 2024: +2.9% −3% 2015 +3% 2016 +27% 2017 −15% 2018 +23% 2019 +9% 2020 +12% 2021 −15% 2022 +16% 2023 +3% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
TROSX+2.9%+4.4%+5.1%
International Stock median+25.5%+6.4%+7.6%

Source: Fund prospectus, as of Dec 31, 2024

Full TROSX performance history →

What TROSX costs

On a $10,000 investment, TROSX's 0.78% expense ratio costs about $78 a year. The prospectus estimates $966 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.

See the full TROSX fee table →

TROSX top 10 holdings

#Holding% of fund
1Asml Holding Nv3.11%
2Siemens Ag-reg2.36%
3Unilever Plc2.06%
4Astrazeneca Plc1.79%
5Taiwan Semiconductor Manufac1.76%
6Shell Plc-adr1.72%
7Totalenergies Se1.71%
8Mitsubishi Ufj Financial Gro1.55%
9Banco Santander Sa1.41%
10Airbus Se1.40%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 18.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to TROSX

More funds like TROSX →

TROSX FAQ

What is the expense ratio of TROSX?
TROSX's expense ratio is 0.78%, which works out to about $78 a year for every $10,000 invested. The prospectus estimates total costs of $966 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is TROSX a good investment?
It depends on your goals, but the data points to: large and established ($24.8 billion). This is general information, not personalized advice.
What does TROSX hold?
TROSX's largest holdings are Asml Holding Nv (3.1%), Siemens Ag-reg (2.4%), Unilever Plc (2.1%), Astrazeneca Plc (1.8%), Taiwan Semiconductor Manufac (1.8%). It holds 142 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is TROSX's 5-year return?
TROSX returned +4.4% a year over the five years ending Dec 31, 2024, and +5.1% a year over ten years. Past performance does not guarantee future results.
Who manages TROSX?
TROSX is offered by T. Rowe Price through T. Rowe Price International Funds, Inc..